Amarin hit hard as generics loom for fish oil drug Vascepa
Amarin, cardiovascular, Dr Reddy's, generic, Hikma, litigation, Vascepa
0 Comment
Hikma
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Advair, asthma, Chronic Obstructive Pulmonary Disease, generic, GlaxoSmithKline, Hikma, Mylan, respiratory, Sandoz
0 Comment
Hikma in dispute with FDA over Advair generic
generic, GlaxoSmithKline, Hikma, Mylan, respiratory, Sandoz
0 Comment
Hikma to give up date in Q1 next year.
GSK gets short term boost as second US Advair generic rejected
GlaxoSmithKline, Hikma, Mylan, respiratory
0 Comment
FDA rejects Hikma drug, regulator has “major” issue with Mylan’s rival.
Vectura and Hikma to develop US asthma generic
asthma, generic, GlaxoSmithKline, Hikma, respiratory, Vectura
0 Comment
Firms extend existing respiratory deal.
Hikma’s new generics business has slow start
Boehringer Ingelheim, generics, Hikma, Takeda
0 Comment
Profits hit as drug approvals delayed.